Drugs / ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06337071 | Mar → Jun 2024 | meningococcal meningitis | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACYW135 Meningococcal Polysaccharide Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06337071 ↗ |
| Modality | Vaccine | “ACYW135 Meningococcal Polysaccharide Conjugate Vaccine” NCT06337071 ↗ |